Comparative Genomics of Gardnerella vaginalis Strains Reveals Substantial Differences in Metabolic and Virulence Potential

Institute for Genomic Biology, University of Illinois, Urbana, Illinois, USA.
PLoS ONE (Impact Factor: 3.23). 08/2010; 5(8):e12411. DOI: 10.1371/journal.pone.0012411
Source: PubMed


Gardnerella vaginalis is described as a common vaginal bacterial species whose presence correlates strongly with bacterial vaginosis (BV). Here we report the genome sequencing and comparative analyses of three strains of G. vaginalis. Strains 317 (ATCC 14019) and 594 (ATCC 14018) were isolated from the vaginal tracts of women with symptomatic BV, while Strain 409-05 was isolated from a healthy, asymptomatic individual with a Nugent score of 9.
Substantial genomic rearrangement and heterogeneity were observed that appeared to have resulted from both mobile elements and substantial lateral gene transfer. These genomic differences translated to differences in metabolic potential. All strains are equipped with significant virulence potential, including genes encoding the previously described vaginolysin, pili for cytoadhesion, EPS biosynthetic genes for biofilm formation, and antimicrobial resistance systems, We also observed systems promoting multi-drug and lantibiotic extrusion. All G. vaginalis strains possess a large number of genes that may enhance their ability to compete with and exclude other vaginal colonists. These include up to six toxin-antitoxin systems and up to nine additional antitoxins lacking cognate toxins, several of which are clustered within each genome. All strains encode bacteriocidal toxins, including two lysozyme-like toxins produced uniquely by strain 409-05. Interestingly, the BV isolates encode numerous proteins not found in strain 409-05 that likely increase their pathogenic potential. These include enzymes enabling mucin degradation, a trait previously described to strongly correlate with BV, although commonly attributed to non-G. vaginalis species.
Collectively, our results indicate that all three strains are able to thrive in vaginal environments, and therein the BV isolates are capable of occupying a niche that is unique from 409-05. Each strain has significant virulence potential, although genomic and metabolic differences, such as the ability to degrade mucin, indicate that the detection of G. vaginalis in the vaginal tract provides only partial information on the physiological potential of the organism.

Download full-text


Available from: Carl James Yeoman
  • Source
    • "[20] [24] Bacterial density within the biofilm is on the order of 10 10 e10 12 cells per gram compared to 10 6 e10 8 cells per gram of dispersed GV found in vaginal fluid washings. Yeoman et al. suggest that different GV strains have substantially different metabolic and virulence potentials [21]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vulvovaginitis (VV) is one of the most commonly encountered problems by a gynecologist. Many women frequently self-treat with over-the-counter medications, and may present to their health-care provider after a treatment failure. Vulvovaginal candidiasis, bacterial vaginosis, and trichomoniasis may occur as discreet or recurrent episodes, and have been associated with significant treatment cost and morbidity. We present an update on diagnostic capabilities and treatment modalities that address recurrent and refractory episodes of VV.
    Full-text · Article · Jul 2014 · Bailli&egrave re s Best Practice and Research in Clinical Obstetrics and Gynaecology
  • Source
    • "Understanding the function of different microbes across species will also be crucial for understanding the dynamics of host-microbe interactions, health and disease , and facilitating the development of new strategies for disease diagnosis and prevention and for personalized treatments to improve the quality of women's lives. Functional differences cannot be assumed simply by species identification due to species-level or strain-level genomic heterogeneity (Yeoman et al., 2010). Metagenomics can help to identify the functional properties of the microbiomes and the extent of fuctional redundancy across hosts. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The primate body hosts trillions of microbes. Interactions between primate hosts and these microbes profoundly affect primate physiology, reproduction, health, survival, and ultimately, evolution. It is increasingly clear that primate health cannot be understood fully without knowledge of host-microbial interactions. Our goals here are to review what is known about microbiomes of the female reproductive tract and to explore several factors that influence variation within individuals, as well as within and between primate species. Much of our knowledge of microbial variation derives from studies of humans, and from microbes located in nonreproductive regions (e.g., the gut). We review work suggesting that the vaginal microbiota affects female health, fecundity, and pregnancy outcomes, demonstrating the selective potential for these agents. We explore the factors that correlate with microbial variation within species. Initial colonization by microbes depends on the manner of birth; most microbial variation is structured by estrogen levels that change with age (i.e., at puberty and menopause) and through the menstrual cycle. Microbial communities vary by location within the vagina and can depend on the sampling methods used (e.g., swab, lavage, or pap smear). Interindividual differences also exist, and while this variation is not completely understood, evidence points more to differences in estrogen levels, rather than differences in external physical environment. When comparing across species, reproductive-age humans show distinct microbial communities, generally dominated by Lactobacillus, unlike other primates. We develop evolutionary hypotheses to explain the marked differences in microbial communities. While much remains to be done to test these hypotheses, we argue that the ample variation in primate mating and reproductive behavior offers excellent opportunities to evaluate host-microbe coevolution and adaptation.
    Full-text · Article · Dec 2013 · American Journal of Physical Anthropology
  • Source
    • "More recently, advances in next generation sequencing technology have allowed the differentiation of G. vaginalis strains and subgroups according to sequence variations in 16S rRNA and the cpn60 genes, as well as whole genome sequencing analysis (Ahmed et al., 2012; Eren et al., 2011; Paramel Jayaprakash et al., 2012). Genome-level comparisons demonstrated significant divergence between G. vaginalis strains isolated from BV patients and healthy women (Harwich et al., 2010; Yeoman et al., 2010). The comprehensive analysis of the genomes of 17 G. vaginalis clinical isolates revealed profound differences in genome size, G+C DNA content and genic composition, allowing their separation into four clades with distinct gene pools and genomic properties (Ahmed et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gardnerella vaginalis is an important component of human vaginal microflora. It is proposed to play a key role in the pathogenesis of bacterial vaginosis (BV), the most common vaginal condition. Here we describe the development, validation and comparative analysis of a novel molecular approach capable of G. vaginalis identification, quantitation and subtyping in noncultured vaginal specimens. Using two qPCR assays, we analyzed G. vaginalis bacterial loads and clade distribution in 60 clinical vaginal swab samples. A very high pathogen prevalence was revealed by species-specific qPCR not only among BV patients (100%), but also in healthy women (97%), although the G. vaginalis concentration was significantly lower in non-BV samples. G. vaginalis clades identified in vaginal specimens by subtyping multiplex qPCR, which targets four clade-specific genetic markers, had frequencies of 53% for clade 1, 25% for clade 2, 32% for clade 3, and 83% for clade 4. Multiple clades were found in 70% of samples. Single G. vaginalis clades were represented by clade 1 and clade 4 in 28% of specimens. A positive association with BV was shown for clade 1 and clade 3, while clade 2 was positively associated with intermediate vaginal microflora, but not with BV. Clade 4 demonstrated no correlation with the disorder. The presence of multiple clades had a high positive association with BV, whereas G. vaginalis identified as a single clade was negatively linked with the condition. Polyclonal G. vaginalis infection may be a risk factor for BV.
    Preview · Article · Nov 2013 · Journal of Medical Microbiology
Show more